Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults
- 23 August 1999
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 59 (2) , 221-226
- https://doi.org/10.1002/(sici)1096-9071(199910)59:2<221::aid-jmv16>3.0.co;2-h
Abstract
Little information about immunity to respiratory syncytial virus (RSV) and disease pathogenesis in elderly persons exists. Humoral immunity to RSV was assessed in 41 young, 56 healthy elderly, and 49 frail elderly adults by measuring baseline RSV specific IgG by enzyme immunoassay (EIA) and microneutralization assay (MNA) in serum. A comparison of the immune response of 11 young and 28 elderly persons with natural RSV infection was also performed. Despite significant differences in age and functional status, no decreases in RSV antibody levels by either EIA or MNA were noted in the elderly compared with the young. Mean baseline MNA titers expressed as log2 were 10.5 ± 1.1 for the young, 10.5 ± 1.5 for the healthy elderly, and 10.9 ± 1.6 for the frail elderly. The frail elderly who attend a daycare had the highest RSV titers to F by EIA at 16.6 ± 2.0, compared with 15.4 ± 1.4 and 15.1 ± 1.4 in the healthy elderly and young, respectively. This finding may reflect recent infection due to their communal setting or increased production of non‐neutralizing antibody. The immune response of older persons to RSV infection was as vigorous as the younger subjects, with 79% having a ≥fourfold rise in MNA titers compared to 64% in the young. These data suggest that the severe clinical manifestations of RSV in the elderly are not due to a significant defect in humoral immunity. J. Med. Virol. 59:221–226, 1999.Keywords
This publication has 21 references indexed in Scilit:
- Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60Vaccine, 1996
- Respiratory Syncytial Virus Is an Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized AdultsThe Journal of Infectious Diseases, 1996
- Aging and the Immune SystemInfectious Diseases in Clinical Practice, 1994
- Respiratory syncytial virus or influenza?The Lancet, 1993
- Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia—RSV recombinants or RSVVaccine, 1992
- Humoral immunity to respiratory syncytial virus infection in the elderlyJournal of Medical Virology, 1992
- Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunizationVaccine, 1990
- An epidemic of respiratory syncytial virus in elderly people: Clinical and serological findingsJournal of Medical Virology, 1990
- A Comparative Study of Tests for Homogeneity of Variances, with Applications to the Outer Continental Shelf Bidding DataTechnometrics, 1981
- Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levelThe Journal of Pediatrics, 1981